News
IBNtxA (3-iodobenzoyl naltrexamine) is a novel μ-opioid receptor (MOR) agonist which is structurally related to the MOR antagonist naltrexone. Recent studies suggest IBNtxA preferentially signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback